Tumour genomes within the BRCA1- and BRCA2-related subgroups were characterised by relatively long stretches of genomic alterations, deletions and copy gains along with occasional high-level amplifications (Figures 3a and 3b). The gene discussed is BRCA2; the disease is neoplasm.